Han-Teo Lee1,2, Young Ah Kim1, Sangho Lee1, Ye-Eun Jung3, Hanbyeol Kim1,4, Tae Wan Kim5, Sojung Kwak6, Jaehyeon Kim1, Chul-Hwan Lee1,2,4, Sun-Shin Cha3,7, Jinmi Choi8, Eun-Jung Cho8 and Hong-Duk Youn1,2,*
1Stochastic Stemness Research Center, Department of Biomedical Science, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
2Ischemic/Hypoxic Disease Institute, Seoul National University Medical Research Center, Seoul 03080, Republic of Korea
3Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 03760, Republic of Korea
4Department of Pharmacology, Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
5Department of Interdisciplinary Engineering, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu 42988, Republic of Korea
6Developmental Biology Laboratory, Environmental Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea
7R&D Division, TODD PHARM CO. LTD., Seoul 03760, Republic of Korea
8School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea
*To whom correspondence should be addressed. : Hong-Duk Youn